Vesugen (20 mg Vial) is listed for qualified laboratory research use only.
- Research category: Longevity / Bioregulator Research
- COA verified
- Third-party tested when available
- For research and laboratory use only
Important: This product is not intended for human consumption, medical use, diagnostic use, or treatment of any disease.
Vesugen Dosage Chart
Vesugen is dosed at 500 mcg–2 mg daily via subcutaneous injection in educational protocols. A Lys-Glu-Asp reconstituted with bacteriostatic water yields about 6.67 mg/mL. This information is for research and educational use only.
- Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
- Typical daily range: 500–2000 mcg once daily (gradual titration).
- Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U-100 insulin syringe.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Dosing & Reconstitution Guide
Standard / Gradual Approach (3 mL = ~6.67 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Week 1 | 500 mcg (0.5 mg) | 7.5 units (0.075 mL) |
| Week 2 | 1000 mcg (1.0 mg) | 15 units (0.15 mL) |
| Week 3 | 1500 mcg (1.5 mg) | 22.5 units (0.225 mL) |
| Weeks 4–8+ | 1500–2000 mcg (1.5–2.0 mg) | 22.5–30 units (0.225–0.30 mL) |
Frequency: Inject once daily subcutaneously. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability. Note that Week 1 dosing falls at 7.5 units; a 50-unit syringe with 0.5-unit graduations improves accuracy.
Reconstitution Steps
Supplies Needed
- Peptide Vials (Vesugen, 20 mg each):
- 8 weeks (~84 mg total) ≈ 5 vials
- 12 weeks (~126 mg total) ≈ 7 vials
- 16 weeks (~168 mg total) ≈ 9 vials
- Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
- Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- 8 weeks (5 vials): 15 mL → 2 × 10 mL bottles
- 12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
- 16 weeks (9 vials): 27 mL → 3 × 10 mL bottles
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Protocol Overview
- Goal: Support vascular endothelial function and cellular renewal over time[2].
- Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
- Dose Range: 500–2000 mcg daily with gradual titration.
- Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate unit measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Dosing Protocol
Suggested daily titration approach.
- Start: 500 mcg daily; increase by ~500 mcg weekly as tolerated.
- Target: 1500–2000 mcg daily by Weeks 3–8+.
- Frequency: Once per day (subcutaneous).
- Cycle Length: 8–12 weeks; optional extension to 16 weeks.
- Timing: Any consistent time; rotate injection sites.
Reviews
There are no reviews yet.